Skip to content
Cabergoline is a potent dopamine agonist that has garnered attention in the medical community for its application in managing various conditions stemming from hyperprolactinemia, among others. Manufactured by Astera Labs, this pharmaceutical compound functions primarily by inhibiting the secretion of prolactin from the pituitary gland, thus offering therapeutic benefits for patients with elevated prolactin levels.
The pharmacological action of Cabergoline by Astera Labs is detailed on the order in store Cabergoline Astera Labs page.
Key Pharmacological Properties
Cabergoline possesses several key pharmacological properties that contribute to its effectiveness:
- Dopamine Agonism: Cabergoline mimics the action of dopamine, a neurotransmitter that plays a crucial role in regulating mood, behavior, and endocrine functions.
- Prolactin Level Reduction: The primary therapeutic action of Cabergoline is to decrease excessive prolactin levels, which can lead to various health issues including infertility and menstrual disturbances.
- Long Half-life: Its long half-life allows for effective management of symptoms with less frequent dosing compared to other treatments.
- Improved Tolerability: Many patients experience fewer side effects with Cabergoline compared to other dopamine agonists.
Applications of Cabergoline
Cabergoline is commonly used in the treatment of:
- Hyperprolactinemia
- Prolactinoma, a type of pituitary tumor
- Conditions associated with Parkinson’s disease
In conclusion, Cabergoline by Astera Labs acts as a powerful tool in the management of elevated prolactin levels and related disorders, offering patients a viable option to restore hormonal balance and improve their quality of life.